Tuberculosis News and Research

Latest Tuberculosis News and Research

WHO/AFRO: Ghana, Kenya, and Malawi to participate in malaria vaccine pilot program

The World Health Organization Regional Office for Africa announced today that Ghana, Kenya, and Malawi will take part in a WHO-coordinated malaria vaccine implementation programme (MVIP) that will make the world’s first malaria vaccine available in selected areas, beginning in 2018.

26 Apr 2017

WHO Global Hepatitis Report reveals goal to eliminate viral hepatitis by 2030

The World Health Organization (WHO) has published the first-ever Global Hepatitis Report. The World Hepatitis Alliance (WHA) welcomes the publication, which is a follow-up to WHO’s Global Strategy on Viral Hepatitis, and has set the goal to eliminate viral hepatitis as a public health threat by 2030.

21 Apr 2017

New study reports long-term infectious disease trends in China after SARS outbreak

Following the severe acute respiratory syndrome (SARS) outbreak in 2003, China stepped up its prevention and control methods for all infectious diseases, and rates of infection have levelled off since 2009.

19 Apr 2017

Rutgers scientists reveal structure of TB drug target and identify new inhibitors

Rutgers University scientists have determined the three-dimensional structure of the target of the first-line anti-tuberculosis drug rifampin. They have also discovered a new class of potential anti-tuberculosis drugs that kill rifampin-resistant and multi-drug-resistant tuberculosis bacteria.

7 Apr 2017

Epigem partners with Northumbria University to develop disposable TB testing kit

Leading micro-engineering company Epigem today announced a new Knowledge Transfer Partnership with Northumbria University to develop a cost-effective tuberculosis (TB) testing kit.

From Epigem Ltd. 6 Apr 2017

LSTM scientists describe new approach to screening potential TB treatments

Scientists from LSTM's Research Centre for Drugs and Diagnostics (RCDD) have described in a paper published today in Scientific Reports, a new way of screening potential treatments for Tuberculosis (TB) which may assist in the identification and prioritisation of new therapies which could potentially reduce the duration of current TB treatment.

29 Mar 2017

Disease of antiquity: University of Notre Dame expert focuses on tuberculosis research

In the time it takes to read this article, half a dozen people will have died from tuberculosis. It is a cruel and persistent killer, claiming 1.8 million lives each year, an estimated 200,000 of which are children, according to the World Health Organization.

27 Mar 2017

Report: Global increase in drug-resistant TB threatens to ruin efforts to eradicate the disease

The rise of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) threatens to derail decades of progress in controlling the disease, according to a new report in The Lancet Respiratory Medicine published on World TB day (24th March).

25 Mar 2017

WHO launches new ethics guidance to protect rights of TB patients

New tuberculosis (TB) ethics guidance, launched today by the World Health Organization, aims to help ensure that countries implementing the End TB Strategy adhere to sound ethical standards to protect the rights of all those affected.

25 Mar 2017

Fight against TB threatened by drug resistance

Today is World TB Day. Although there is much to celebrate, with 49 million lives being saved through the diagnosis and treatment of tuberculosis (TB) between 2000 and 2015, the rise in TB-causing bacteria that are resistant to key treatments now threatens to derail decades of progress in controlling TB.

24 Mar 2017

New TB/HIV co-infections flare-up by 40% over last five years across Europe

New data released today by the European Centre for Disease Prevention and Control and the WHO Regional Office for Europe ahead of World TB Day show that new tuberculosis cases and deaths in the 53 countries of the WHO European Region declined each year by 4.3% and 8.5% respectively between 2011 and 2015.

20 Mar 2017

TB Alliance urges WHO to add Mycobacterium tuberculosis to list of drug-resistant bacteria

TB Alliance and the broader TB community urge that the World Health Organization (WHO) add Mycobacterium tuberculosis to the critical group within the list of drug-resistant bacteria identified as urgent priorities for research and development.

3 Mar 2017

WHO releases first ever list of antibiotic-resistant 'priority pathogens'

The World Health Organization today published its first ever list of antibiotic-resistant “priority pathogens”—a catalogue of 12 families of bacteria that pose the greatest threat to human health.

3 Mar 2017

Case Western Reserve and VA team up to tackle rising problem of antibiotic resistance

Since the discovery of penicillin in 1928, antibiotics have made the world a much safer and healthier place. But Shakespeare was onto something when he asked if it's possible to have too much of a good thing. In the case of antibiotics, the answer is increasingly "yes."

3 Mar 2017

Compound from soil bacteria could translate into new drug lead for TB

A new treatment for tuberculosis (TB) is set to be developed using compounds derived from bacteria that live in soil - according an international collaboration of researchers, including the University of Warwick.

1 Mar 2017

WSU study aims to reduce burden of antimicrobial resistance

The death last year of a woman in Reno, Nev., from an infection resistant to every type of antibiotic available in the U.S. highlights how serious the threat of antimicrobial resistance has become.

1 Mar 2017

Diagnosing Infections Through Molecules in Patient Breath

Over the past couple of decades, the analytical technology and the clinical microbiology insight needed to create a breath test for infections has seen a considerable number of advances and there are now numerous research teams focused on evaluating patient breath as a diagnostic fluid for infectious diseases. Significant challenges still need to be overcome.

From Pittcon 27 Feb 2017

Tuberculosis News and Research

Latest Tuberculosis News and Research

WHO/AFRO: Ghana, Kenya, and Malawi to participate in malaria vaccine pilot program

WHO Global Hepatitis Report reveals goal to eliminate viral hepatitis by 2030

New study reports long-term infectious disease trends in China after SARS outbreak

Rutgers scientists reveal structure of TB drug target and identify new inhibitors

Epigem partners with Northumbria University to develop disposable TB testing kit

LSTM scientists describe new approach to screening potential TB treatments

Disease of antiquity: University of Notre Dame expert focuses on tuberculosis research

Report: Global increase in drug-resistant TB threatens to ruin efforts to eradicate the disease

WHO launches new ethics guidance to protect rights of TB patients

Fight against TB threatened by drug resistance

New TB/HIV co-infections flare-up by 40% over last five years across Europe

TB Alliance urges WHO to add Mycobacterium tuberculosis to list of drug-resistant bacteria

WHO releases first ever list of antibiotic-resistant 'priority pathogens'

Case Western Reserve and VA team up to tackle rising problem of antibiotic resistance

Compound from soil bacteria could translate into new drug lead for TB

WSU study aims to reduce burden of antimicrobial resistance

Diagnosing Infections Through Molecules in Patient Breath

Scientists identify novel mutations in bacteria that promote evolution of antibiotic resistance

New article provides thought-provoking view on the rise of allergy, autoimmune diseases

Survey findings reveal amazing progress in confronting HIV epidemic in Zimbabwe, Malawi, and Zambia

Forensics and toxicology - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Tuberculosis News and Research

Latest Tuberculosis News and Research

Forensics and toxicology - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in